Asset Management One Co. Ltd. Has $16.84 Million Stock Holdings in Kenvue Inc. (NYSE:KVUE)

Asset Management One Co. Ltd. decreased its stake in shares of Kenvue Inc. (NYSE:KVUE) by 0.8% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 728,035 shares of the company’s stock after selling 5,817 shares during the quarter. Asset Management One Co. Ltd.’s holdings in Kenvue were worth $16,839,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. National Pension Service increased its holdings in Kenvue by 14.5% during the third quarter. National Pension Service now owns 2,829,772 shares of the company’s stock worth $65,453,000 after buying an additional 357,672 shares during the last quarter. Cohen Capital Management Inc. grew its position in shares of Kenvue by 1.6% in the 3rd quarter. Cohen Capital Management Inc. now owns 168,193 shares of the company’s stock valued at $3,890,000 after acquiring an additional 2,640 shares during the period. CORDA Investment Management LLC. increased its stake in shares of Kenvue by 1.3% during the 3rd quarter. CORDA Investment Management LLC. now owns 1,235,630 shares of the company’s stock worth $28,580,000 after purchasing an additional 16,270 shares during the last quarter. Allen Wealth Management LLC raised its holdings in shares of Kenvue by 14.4% in the 3rd quarter. Allen Wealth Management LLC now owns 76,558 shares of the company’s stock valued at $1,771,000 after purchasing an additional 9,618 shares during the period. Finally, New York State Common Retirement Fund lifted its stake in Kenvue by 57.4% in the 3rd quarter. New York State Common Retirement Fund now owns 2,226,323 shares of the company’s stock valued at $51,495,000 after purchasing an additional 811,783 shares during the last quarter. Institutional investors own 97.64% of the company’s stock.

Analyst Ratings Changes

Several analysts have issued reports on the company. UBS Group upped their price objective on Kenvue from $20.00 to $22.00 and gave the company a “neutral” rating in a research note on Wednesday, August 7th. Piper Sandler increased their price target on Kenvue from $20.00 to $21.00 and gave the company a “neutral” rating in a research note on Monday, September 23rd. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Kenvue from $23.00 to $24.00 and gave the stock a “buy” rating in a research report on Wednesday, August 7th. JPMorgan Chase & Co. increased their price objective on shares of Kenvue from $24.00 to $25.00 and gave the company an “overweight” rating in a research report on Friday, October 11th. Finally, Bank of America lifted their target price on shares of Kenvue from $24.00 to $27.00 and gave the stock a “buy” rating in a report on Tuesday, October 22nd. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $22.64.

Kenvue Stock Performance

Shares of NYSE:KVUE opened at $23.23 on Wednesday. Kenvue Inc. has a 12-month low of $17.67 and a 12-month high of $23.57. The company’s 50 day moving average price is $22.57 and its two-hundred day moving average price is $20.47. The firm has a market cap of $44.48 billion, a PE ratio of 40.04, a PEG ratio of 2.97 and a beta of 1.36. The company has a quick ratio of 0.68, a current ratio of 0.99 and a debt-to-equity ratio of 0.69.

Kenvue (NYSE:KVUE) last posted its quarterly earnings data on Tuesday, August 6th. The company reported $0.32 EPS for the quarter, topping analysts’ consensus estimates of $0.28 by $0.04. The firm had revenue of $4 billion for the quarter, compared to analyst estimates of $3.93 billion. Kenvue had a return on equity of 21.80% and a net margin of 7.23%. The company’s revenue was down .3% on a year-over-year basis. During the same quarter last year, the company earned $0.32 EPS. Equities research analysts predict that Kenvue Inc. will post 1.08 earnings per share for the current year.

Kenvue Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, November 27th. Investors of record on Wednesday, November 13th will be given a $0.205 dividend. This represents a $0.82 dividend on an annualized basis and a dividend yield of 3.53%. The ex-dividend date is Wednesday, November 13th. Kenvue’s payout ratio is currently 141.38%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.